CDC Concerned About Falling Flu Vaccination Rates

Share this content:
CDC Concerned About Falling Flu Vaccination Rates
CDC Concerned About Falling Flu Vaccination Rates

FRIDAY, Sept. 30, 2016 (HealthDay News) -- Influenza vaccination coverage declined 1.5 percent across the entire U.S. population during the 2015-2016 flu season, with only 46 percent of Americans receiving the annual vaccine, the U.S. Centers for Disease Control and Prevention announced Thursday.

Adults 50 and older experienced the greatest decreases in vaccination coverage last flu season, the CDC numbers revealed. There was a 3.4 percentage point decrease in flu vaccinations among people 50 to 64 years old, with less than 44 percent receiving vaccination. A similar decrease of 3.3 percentage points occurred among people 65 and older, with 63 percent receiving the protection.

Toddlers were the best-protected age group during the last flu season, the CDC reported. Flu vaccine coverage for children 6 to 23 months was 75 percent. This is also the only group that exceeded national public health goals of 70 percent vaccination coverage. However, there is some concern that some parents might not get their children vaccinated this season because only injectable flu vaccine is available.

"The nasal spray is no longer recommended," Tom Frieden, M.D., M.P.H., director of the CDC, said during a news conference. "We don't know why, but the vaccine efficacy data from the past couple of years suggests it was not protective." About one-third of children who get vaccinated against the flu take the nasal spray, experts at the briefing said. They encouraged those parents to get their children a flu shot instead.

More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths